RxDoctor Payments Data

Jeffrey Garris, MD

Obstetrics & Gynecology · Arden, NCNPI 1295842029

Payments from drug & device makers

$10,983in general payments, 2019–2025

Across 226 payments — averaging $48.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$5K
  • Medtronic$3K
  • Intuitive Surgical$1K
  • AbbVie$561
  • Coloplast$360
  • Astellas Pharma US Inc$226
  • plus $1K from 15 others

What the payments were for

  • Speaking & faculty fees$2732%
  • Travel & lodging$3,60533%
  • Food & beverage$6,59760%
  • Education$5075%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,983 in reported general payments places this provider in the 90th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

See all obstetrics & gynecology providers in North Carolina

Medicare billing

Part B allowed, 2024
$70,769
Medicare patients
173
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron23$22,147
PremarinEstrogens, Conjugated25$10,159
Solifenacin Succinate148$4,557
PremproEstrogen,con/M-Progest Acet13$3,197
Methenamine Hippurate58$2,820
Estradiol23$1,418
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst39$1,128
NitrofurantoinNitrofurantoin Macrocrystal18$584
Gabapentin23$235
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$232
Cephalexin19$159
Doxycycline Hyclate28$152
Metronidazole11$127
Oxybutynin Chloride ErOxybutynin Chloride12$107
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$92

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$226$22,14723 claims
PfizerPremarin, Prempro$120$13,35638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

Other obstetrics & gynecology in Arden

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →